Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke.

Yamaguchi I, Kanematsu Y, Shimada K, Korai M, Miyamoto T, Shikata E, Yamaguchi T, Yamamoto N, Yamamoto Y, Kitazato KT, Okayama Y, Takagi Y.

Cerebrovasc Dis Extra. 2019 Nov 22;9(3):129-138. doi: 10.1159/000504163. [Epub ahead of print]

2.

Time-dependent and site-dependent morphological changes in rupture-prone arteries: ovariectomized rat intracranial aneurysm model.

Yamaguchi T, Miyamoto T, Kitazato KT, Shikata E, Yamaguchi I, Korai M, Shimada K, Yagi K, Tada Y, Matsuzaki Y, Kanematsu Y, Takagi Y.

J Neurosurg. 2019 Sep 13:1-9. doi: 10.3171/2019.6.JNS19777. [Epub ahead of print]

PMID:
31518986
3.

Importance of Managing the Water-Electrolyte Balance by Delivering the Optimal Minimum Amount of Water and Sodium After Subarachnoid Hemorrhage.

Shikata E, Tamura T, Shinno K, Okayama Y, Shinohara N, Shimada K, Kanematsu Y, Kitazato KT, Nagahiro S, Takagi Y.

World Neurosurg. 2019 Sep;129:e352-e360. doi: 10.1016/j.wneu.2019.05.152. Epub 2019 May 25.

PMID:
31132492
4.

Down-regulation of MDR1 by Ad-DKK3 via Akt/NFκB pathways augments the anti-tumor effect of temozolomide in glioblastoma cells and a murine xenograft model.

Fujihara T, Mizobuchi Y, Nakajima K, Kageji T, Matsuzaki K, Kitazato KT, Otsuka R, Hara K, Mure H, Okazaki T, Kuwayama K, Nagahiro S, Takagi Y.

J Neurooncol. 2018 Sep;139(2):323-332. doi: 10.1007/s11060-018-2894-5. Epub 2018 May 19.

PMID:
29779087
5.

Treatment of Unruptured Cerebral Aneurysms with the Mineralocorticoid Receptor Blocker Eplerenone-Pilot Study.

Nagahiro S, Tada Y, Satomi J, Kinouchi T, Kuwayama K, Yagi K, Nakajima K, Matsushita N, Miyamoto T, Yamaguchi T, Shimada K, Korai M, Mure H, Okayama Y, Abe T, Harada M, Kitazato KT, Kanematsu Y.

J Stroke Cerebrovasc Dis. 2018 Aug;27(8):2134-2140. doi: 10.1016/j.jstrokecerebrovasdis.2018.03.008. Epub 2018 Apr 2.

6.

Correction to: Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats.

Kinouchi T, Kitazato KT, Shimada K, Yagi K, Tada Y, Matsushita N, Kurashiki Y, Satomi J, Sata M, Nagahiro S.

Transl Stroke Res. 2018 Jun;9(3):317. doi: 10.1007/s12975-017-0589-4.

7.

Treatment with the PPARγ Agonist Pioglitazone in the Early Post-ischemia Phase Inhibits Pro-inflammatory Responses and Promotes Neurogenesis Via the Activation of Innate- and Bone Marrow-Derived Stem Cells in Rats.

Kinouchi T, Kitazato KT, Shimada K, Yagi K, Tada Y, Matsushita N, Kurashiki Y, Satomi J, Sata M, Nagahiro S.

Transl Stroke Res. 2018 Jun;9(3):306-316. doi: 10.1007/s12975-017-0577-8. Epub 2017 Nov 6. Erratum in: Transl Stroke Res. 2017 Nov 26;:.

8.

Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats.

Maekawa H, Tada Y, Yagi K, Miyamoto T, Kitazato KT, Korai M, Satomi J, Hashimoto T, Nagahiro S.

J Neuroinflammation. 2017 Oct 2;14(1):197. doi: 10.1186/s12974-017-0966-7.

9.

Intra-arterial high signals on arterial spin labeling perfusion images predict the occluded internal carotid artery segment.

Sogabe S, Satomi J, Tada Y, Kanematsu Y, Kuwayama K, Yagi K, Yoshioka S, Mizobuchi Y, Mure H, Yamaguchi I, Abe T, Yamamoto N, Kitazato KT, Kaji R, Harada M, Nagahiro S.

Neuroradiology. 2017 Jun;59(6):587-595. doi: 10.1007/s00234-017-1828-9. Epub 2017 Apr 10.

PMID:
28397019
10.

Site-specific elevation of interleukin-1β and matrix metalloproteinase-9 in the Willis circle by hemodynamic changes is associated with rupture in a novel rat cerebral aneurysm model.

Miyamoto T, Kung DK, Kitazato KT, Yagi K, Shimada K, Tada Y, Korai M, Kurashiki Y, Kinouchi T, Kanematsu Y, Satomi J, Hashimoto T, Nagahiro S.

J Cereb Blood Flow Metab. 2017 Aug;37(8):2795-2805. doi: 10.1177/0271678X16675369. Epub 2016 Jan 1.

11.

Hyperhomocysteinemia induced by excessive methionine intake promotes rupture of cerebral aneurysms in ovariectomized rats.

Korai M, Kitazato KT, Tada Y, Miyamoto T, Shimada K, Matsushita N, Kanematsu Y, Satomi J, Hashimoto T, Nagahiro S.

J Neuroinflammation. 2016 Jun 27;13(1):165. doi: 10.1186/s12974-016-0634-3.

12.

The accumulation of brain water-free sodium is associated with ischemic damage independent of the blood pressure in female rats.

Sumiyoshi M, Kitazato KT, Yagi K, Miyamoto T, Kurashiki Y, Matsushita N, Kinouchi T, Kuwayama K, Satomi J, Nagahiro S.

Brain Res. 2015 Aug 7;1616:37-44. doi: 10.1016/j.brainres.2015.04.051. Epub 2015 May 7.

13.

Protective Role of Peroxisome Proliferator-Activated Receptor-γ in the Development of Intracranial Aneurysm Rupture.

Shimada K, Furukawa H, Wada K, Korai M, Wei Y, Tada Y, Kuwabara A, Shikata F, Kitazato KT, Nagahiro S, Lawton MT, Hashimoto T.

Stroke. 2015 Jun;46(6):1664-72. doi: 10.1161/STROKEAHA.114.007722. Epub 2015 Apr 30.

14.

PPARγ-Dependent and -Independent Inhibition of the HMGB1/TLR9 Pathway by Eicosapentaenoic Acid Attenuates Ischemic Brain Damage in Ovariectomized Rats.

Sumiyoshi M, Satomi J, Kitazato KT, Yagi K, Shimada K, Kurashiki Y, Korai M, Miyamoto T, Suzue R, Kuwayama K, Nagahiro S.

J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1187-95. doi: 10.1016/j.jstrokecerebrovasdis.2015.01.009. Epub 2015 Apr 25.

15.

Improvement of Plasma Biomarkers after Switching Stroke Patients from Other Angiotensin II Type I Receptor Blockers to Olmesartan.

Tada Y, Yagi K, Uno M, Matsushita N, Kanematsu Y, Kuwayama K, Shimada K, Nishi K, Hirasawa M, Satomi J, Kitazato KT, Kageji T, Matsuura E, Nagahiro S.

J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1487-92. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.015. Epub 2015 Apr 16.

16.

Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice.

Shimada K, Furukawa H, Wada K, Wei Y, Tada Y, Kuwabara A, Shikata F, Kanematsu Y, Lawton MT, Kitazato KT, Nagahiro S, Hashimoto T.

J Cereb Blood Flow Metab. 2015 Jul;35(7):1163-8. doi: 10.1038/jcbfm.2015.30. Epub 2015 Mar 11.

17.

Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma.

Hara K, Kageji T, Mizobuchi Y, Kitazato KT, Okazaki T, Fujihara T, Nakajima K, Mure H, Kuwayama K, Hara T, Nagahiro S.

Cancer Lett. 2015 Jan 28;356(2 Pt B):496-505. doi: 10.1016/j.canlet.2014.09.045. Epub 2014 Oct 6.

PMID:
25301448
18.

Roles of estrogen in the formation of intracranial aneurysms in ovariectomized female mice.

Tada Y, Makino H, Furukawa H, Shimada K, Wada K, Liang EI, Murakami S, Kudo M, Kung DK, Hasan DM, Kitazato KT, Nagahiro S, Lawton MT, Hashimoto T.

Neurosurgery. 2014 Dec;75(6):690-5; discussion 695. doi: 10.1227/NEU.0000000000000528.

19.

Estrogen protects against intracranial aneurysm rupture in ovariectomized mice.

Tada Y, Wada K, Shimada K, Makino H, Liang EI, Murakami S, Kudo M, Shikata F, Pena Silva RA, Kitazato KT, Hasan DM, Kanematsu Y, Nagahiro S, Hashimoto T.

Hypertension. 2014 Jun;63(6):1339-44. doi: 10.1161/HYPERTENSIONAHA.114.03300. Epub 2014 Apr 14.

20.

Roles of hypertension in the rupture of intracranial aneurysms.

Tada Y, Wada K, Shimada K, Makino H, Liang EI, Murakami S, Kudo M, Kitazato KT, Nagahiro S, Hashimoto T.

Stroke. 2014 Feb;45(2):579-86. doi: 10.1161/STROKEAHA.113.003072. Epub 2013 Dec 26.

21.

Increase in body Na+/water ratio is associated with cerebral aneurysm formation in oophorectomized rats.

Matsushita N, Kitazato KT, Tada Y, Sumiyoshi M, Shimada K, Yagi K, Kanematsu Y, Satomi J, Nagahiro S.

Hypertension. 2012 Nov;60(5):1309-15. doi: 10.1161/HYPERTENSIONAHA.112.198762. Epub 2012 Oct 8.

PMID:
23045463
22.

Up-regulation of endogenous PML induced by a combination of interferon-beta and temozolomide enhances p73/YAP-mediated apoptosis in glioblastoma.

Okazaki T, Kageji T, Kuwayama K, Kitazato KT, Mure H, Hara K, Morigaki R, Mizobuchi Y, Matsuzaki K, Nagahiro S.

Cancer Lett. 2012 Oct 28;323(2):199-207. doi: 10.1016/j.canlet.2012.04.013. Epub 2012 Apr 24.

PMID:
22542810
23.

Krüppel-like zinc-finger transcription factor 5 (KLF5) is highly expressed in large and giant unruptured cerebral aneurysms.

Nakajima N, Nagahiro S, Sano T, Satomi J, Tada Y, Yagi K, Kitazato KT, Satoh K.

World Neurosurg. 2012 Jul;78(1-2):114-21. doi: 10.1016/j.wneu.2011.05.052. Epub 2011 Nov 7.

PMID:
22120375
24.

Activation of signal transducer and activator of transcription-3 by a peroxisome proliferator-activated receptor gamma agonist contributes to neuroprotection in the peri-infarct region after ischemia in oophorectomized rats.

Kinouchi T, Kitazato KT, Shimada K, Yagi K, Tada Y, Matsushita N, Sumiyoshi M, Satomi J, Kageji T, Nagahiro S.

Stroke. 2012 Feb;43(2):478-83. doi: 10.1161/STROKEAHA.111.618926. Epub 2011 Nov 10.

PMID:
22076002
25.

Statins promote the growth of experimentally induced cerebral aneurysms in estrogen-deficient rats.

Tada Y, Kitazato KT, Yagi K, Shimada K, Matsushita N, Kinouchi T, Kanematsu Y, Satomi J, Kageji T, Nagahiro S.

Stroke. 2011 Aug;42(8):2286-93. doi: 10.1161/STROKEAHA.110.608034. Epub 2011 Jul 7.

PMID:
21737796
26.

Activation of estrogen receptor-α and of angiotensin-converting enzyme 2 suppresses ischemic brain damage in oophorectomized rats.

Shimada K, Kitazato KT, Kinouchi T, Yagi K, Tada Y, Satomi J, Kageji T, Nagahiro S.

Hypertension. 2011 Jun;57(6):1161-6. doi: 10.1161/HYPERTENSIONAHA.110.167650. Epub 2011 May 2.

PMID:
21536991
27.

Reduction of endothelial tight junction proteins is related to cerebral aneurysm formation in rats.

Tada Y, Yagi K, Kitazato KT, Tamura T, Kinouchi T, Shimada K, Matsushita N, Nakajima N, Satomi J, Kageji T, Nagahiro S.

J Hypertens. 2010 Sep;28(9):1883-91. doi: 10.1097/HJH;0b013e32833c2273.

PMID:
20577123
28.

Akt2 and Akt3 play a pivotal role in malignant gliomas.

Mure H, Matsuzaki K, Kitazato KT, Mizobuchi Y, Kuwayama K, Kageji T, Nagahiro S.

Neuro Oncol. 2010 Mar;12(3):221-32. doi: 10.1093/neuonc/nop026. Epub 2009 Dec 21.

29.

Ibudilast inhibits cerebral aneurysms by down-regulating inflammation-related molecules in the vascular wall of rats.

Yagi K, Tada Y, Kitazato KT, Tamura T, Satomi J, Nagahiro S.

Neurosurgery. 2010 Mar;66(3):551-9; discussion 559. doi: 10.1227/01.NEU.0000365771.89576.77.

PMID:
20124930
30.

Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.

Tada Y, Kitazato KT, Tamura T, Yagi K, Shimada K, Kinouchi T, Satomi J, Nagahiro S.

Hypertension. 2009 Sep;54(3):552-7. doi: 10.1161/HYPERTENSIONAHA.109.134130. Epub 2009 Jul 20.

PMID:
19620512
31.

Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats.

Tamura T, Jamous MA, Kitazato KT, Yagi K, Tada Y, Uno M, Nagahiro S.

J Hypertens. 2009 Jun;27(6):1284-92. doi: 10.1097/HJH.0b013e328329d1a7.

PMID:
19307983
32.

Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.

Yagi K, Kitazato KT, Uno M, Tada Y, Kinouchi T, Shimada K, Nagahiro S.

Stroke. 2009 Feb;40(2):626-31. doi: 10.1161/STROKEAHA.108.520262. Epub 2008 Dec 18.

PMID:
19095969
33.

Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.

Kuwayama K, Matsuzaki K, Mizobuchi Y, Mure H, Kitazato KT, Kageji T, Nakao M, Nagahiro S.

Neuro Oncol. 2009 Apr;11(2):132-41. doi: 10.1215/15228517-2008-083. Epub 2008 Sep 23.

34.

Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.

Liu H, Kitazato KT, Uno M, Yagi K, Kanematsu Y, Tamura T, Tada Y, Kinouchi T, Nagahiro S.

J Hypertens. 2008 Jul;26(7):1435-45. doi: 10.1097/HJH.0b013e3283013b6e.

PMID:
18551021
35.
36.

Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: experimental study in rats.

Jamous MA, Nagahiro S, Kitazato KT, Tamura T, Aziz HA, Shono M, Satoh K.

J Neurosurg. 2007 Aug;107(2):405-11.

PMID:
17695397
37.

Immunoreactive circulating oxidized HDL concentrations do not increase in patients undergoing carotid endarterectomy: a comparative study for oxidized HDL and oxidized LDL concentrations in plasma.

Nakano T, Seo M, Komoda T, Kitazato KT, Uno M, Hamaoki M, Nagata A.

Clin Chim Acta. 2007 Jun;381(2):179-81. Epub 2007 Mar 19. No abstract available.

PMID:
17462613
38.
39.
40.

Contribution of an imbalance between oxidant-antioxidant systems to plaque vulnerability in patients with carotid artery stenosis.

Uno M, Kitazato KT, Suzue A, Itabe H, Hao L, Nagahiro S.

J Neurosurg. 2005 Sep;103(3):518-25.

PMID:
16235685
41.
42.

Elevation of plasma oxidized LDL in acute stroke patients is associated with ischemic lesions depicted by DWI and predictive of infarct enlargement.

Uno M, Harada M, Takimoto O, Kitazato KT, Suzue A, Yoneda K, Morita N, Itabe H, Nagahiro S.

Neurol Res. 2005 Jan;27(1):94-102.

PMID:
15829167
43.
44.

Peripheral oxidative biomarkers constitute a valuable indicator of the severity of oxidative brain damage in acute cerebral infarction.

Liu H, Uno M, Kitazato KT, Suzue A, Manabe S, Yamasaki H, Shono M, Nagahiro S.

Brain Res. 2004 Oct 29;1025(1-2):43-50.

PMID:
15464743
45.
46.
47.

Raised plasma oxidised LDL in acute cerebral infarction.

Uno M, Kitazato KT, Nishi K, Itabe H, Nagahiro S.

J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):312-6.

48.

Oxidized LDL in carotid plaques and plasma associates with plaque instability.

Nishi K, Itabe H, Uno M, Kitazato KT, Horiguchi H, Shinno K, Nagahiro S.

Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1649-54.

PMID:
12377744
49.

Effect of depolymerized holothurian glycosaminoglycan (DHG) on tissue factor pathway inhibitor: in vitro and in vivo studies.

Nagase H, Enjyoji K, Kamikubo Y, Kitazato KT, Kitazato K, Saito H, Kato H.

Thromb Haemost. 1997 Aug;78(2):864-70.

PMID:
9268186
50.

Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4.

Sasaki E, Minamiguchi K, Kitazato KT, Nagase H, Kitazato K.

Haemostasis. 1997 Jul-Aug;27(4):174-83.

PMID:
9483172

Supplemental Content

Loading ...
Support Center